• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients
CONCLUSIONS: Omalizumab could provide substantial benefits in terms of paid and unpaid work activities in patients with severe and most severe JCP. Our results also highlight the importance of considering unpaid work in estimating productivity costs due to poor health.PMID:35072591 | DOI:10.1080/13696998.2022.2033051
Source: Journal of Medical Economics - January 24, 2022 Category: Health Management Authors: M M üller A Igarashi K Hashiguchi M Kappel F Paolini H Yoshisue M Funakubo H Sharma M Okano Source Type: research

A quality of life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial.
Conclusions: Application of the mapping function enabled the calculation of QALDs associated with the treatment, with the caveat that data were extrapolated from grass seasonal allergy to tree seasonal allergy. The results showed a significant QALD benefit of the treatment over placebo in treatment of tree pollen-induced rhinoconjunctivitis. PMID: 31352853 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - July 31, 2019 Category: Health Management Tags: J Med Econ Source Type: research

The economic advantage of allergen immunotherapy over drug treatment in respiratory allergy.
Authors: Incorvaia C, Gritti BL, Ridolo E PMID: 29295630 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - January 5, 2018 Category: Health Management Tags: J Med Econ Source Type: research

Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain and Switzerland.
CONCLUSION: In patients with allergic rhinitis, SIT offers cost-effective treatment options compared to symptomatic treatment. When comparing SCIT (Allergovit) and SLIT (Oralair), SCIT was dominant in terms of QALYs as well as costs, in particular due to a slightly higher patient compliance and lower drug costs. PMID: 29271271 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - December 23, 2017 Category: Health Management Tags: J Med Econ Source Type: research

Expert panel on practice patterns in the management of cow's milk protein allergy and associated economic burden of disease on health service in Turkey.
CONCLUSIONS: In conclusion, in providing the first health economic data on CMPA in Turkey, our findings revealed that CMPA imposes a substantial burden on the Turkish healthcare system from both payer perspective and societal perspective and indicated clinical nutrition as a primary cost driver. Management of infants presented with eczema, exclusively formula-fed infants, and first line use of AAF were associated with higher estimates for 2-year direct medical costs. PMID: 28602101 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - June 14, 2017 Category: Health Management Tags: J Med Econ Source Type: research

Amino acid formula as a new strategy for diagnosing cow's milk allergy in infants: is it cost-effective?
CONCLUSIONS: The new strategy, which uses an amino acid formula in the elimination diagnostic diet followed by an oral food challenge, is a dominant pharmacoeconomic approach that has a lower cost and results in an increased number of symptom-free days. PMID: 27441755 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - July 23, 2016 Category: Health Management Tags: J Med Econ Source Type: research

Amino acid formula as a new strategy for diagnosing cow´s milk allergy in infants: is it cost-effective?
CONCLUSIONS: The new strategy, which uses an amino acid formula in the elimination diagnostic diet followed by an oral food challenge, is a dominant pharmacoeconomic approach that has a lower cost and results in an increased number of symptom-free days. PMID: 27152743 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - May 8, 2016 Category: Health Management Tags: J Med Econ Source Type: research

Cost-minimisation analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
CONCLUSION: With regards to the cost of treating Danish patients with HDM RAD, it is clearly cost-saving to treat patients with SQ® SLIT-tablet compared to SQ® SCIT. PMID: 26909663 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - February 26, 2016 Category: Health Management Tags: J Med Econ Source Type: research